Pathogenesis of Minimal Change Nephrotic Syndrome: A Review of the Underlying Molecular Mechanisms
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Nephrotic syndrome (NS) is the most common glomerular disorder in childhood, and a vast majority of cases are idiopathic. The precise cause of this common childhood disease is not fully elucidated despite significant advancements in our understanding of podocyte biology. Idiopathic NS has been considered “a disorder of T-cell function” mediated by a circulating factor that alters podocyte function resulting in massive proteinuria since the last four decades. Several circulatory factors released from T-cells are considered to be involved in pathophysiology of NS; however, a single presumptive factor has not been defined yet. Extended evidence obtained by advances in the pathobiology of podocytes has implicated podocytes as critical regulator of glomerular protein filtration and podocytopathy. The candidate molecules as pathological mediators of steroid-dependent NS are CD80 (also known as B7-1), hemopexin, and angiopoietin-like 4. The “two-hit” hypothesis proposes that the expression of CD80 on podocytes and ineffective inhibition of podocyte CD80 due to regulatory T-cell dysfunction or impaired autoregulation by podocytes results in NS. Recent studies suggest that not only T cells but also other immune cells and podocytes are involved in the pathogenesis of MCNS.
Abstract
Nephrotic syndrome (NS) is the most common glomerular disorder in childhood, and a vast majority of cases are idiopathic. The precise cause of this common childhood disease is not fully elucidated despite significant advancements in our understanding of podocyte biology. Idiopathic NS has been considered “a disorder of T-cell function” mediated by a circulating factor that alters podocyte function resulting in massive proteinuria since the last four decades. Several circulatory factors released from T-cells are considered to be involved in pathophysiology of NS; however, a single presumptive factor has not been defined yet. Extended evidence obtained by advances in the pathobiology of podocytes has implicated podocytes as critical regulator of glomerular protein filtration and podocytopathy. The candidate molecules as pathological mediators of steroid-dependent NS are CD80 (also known as B7-1), hemopexin, and angiopoietin-like 4. The “two-hit” hypothesis proposes that the expression of CD80 on podocytes and ineffective inhibition of podocyte CD80 due to regulatory T-cell dysfunction or impaired autoregulation by podocytes results in NS. Recent studies suggest that not only T cells but also other immune cells and podocytes are involved in the pathogenesis of MCNS.
참고문헌 (44)
- Noone DG, "Idiopathic nephrotic syndrome in children", Lancet, 392, pp.61~74 (2018)
- Banh TH, "Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome", Clin J AM Soc Nephrol, 11, pp.1760~1768 (2016)
- Kaneko K, "Pathogenesis of childhood idiopathic nephrotic syndrome : a paradigm shift from T-cells to podocytes", World J Pediatr, 11, pp.21~28 (2015)
- Mendonca AC, "A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome", Pediatr Nephrol, 30, pp.2011~2020 (2015)
- Pais Pariya, "Nelson textbook of pediatrics", pp.2521~2526 (2016), Elsevier
- Shalhoub RJ, "Pathogenesis of lipoid nephrosis : a disorder of Tcell function", Lancet, 2, pp.556~560 (1974)
- Koyama A, "A glomerular permeability factor produced by human T cell hybridomas", Kidney Int, 40, pp.453~460 (1991)
- Savin VJ, "Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis", N Engl J Med, 334, pp.878~883 (1996)
- Araya CE, "A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome", Pediatr Nephrol, 21, pp.603~610 (2006)
- Kaneko K., "Molecular mechanism in the pathogenesis of idiopathic nephrotic syndrome" (2016), Springer
- Daniel V, "T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome", Clin Nephrol, 47, pp.289~297 (1997)
- Neuhaus TJ, "Increased IL-2, IL-4and interferon-gamma(IFN-gamma)in steroid-sensitive nephrotic syndrome", Clin Exp Immunol, 100, pp.475~479 (1995)
- Mandreoli M, "Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy", Clin Nephrol, 37, pp.177~182 (1992)
- Garin EH, "IL-8 production by peripheral blood mononuclear cells in nephrotic patients", Kidney Int, 45, pp.1311~1317 (1994)
- Garin EH, "Effect of interleukin-8 on glomerular sulfated compounds and albuminuria", Pediatr Nephrol, 11, pp.274~279 (1997)
- Souto MF, "Immune mediators in idiopathic nephrotic syndrome : evidence for a relation between interleukin 8 and proteinuria", Pediatr Res, 64, pp.637~642 (2008)
- Van Den Berg JG, "Interleukin-4 and-13 promote basolateral secretion of H(+)and cathepsin L by glomerular epithelial cells", Am J Physiol Renal Physiol, 282, pp.F26~33 (2002)
- Lai KW, "Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats", J Am Soc Nephrol, 18, pp.1476~1485 (2007)
- Tain YL, "Implications of serum TNF-beta and IL-13 in the treatment response of childhood nephrotic syndrome", Cytokine, 21, pp.155~159 (2003)
- Suranyi MG, "Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans", Am J Kidney Dis, 21, pp.251~259 (1993)
- Matsumoto K, "Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome", Clin Nephrol, 55, pp.269~274 (2001)
- Cho MH, "Interleukin-8 and tumor necrosis factor-alpha are increased in minimal change disease but do not alter albumin permeability", Am J Nephrol, 23, pp.260~266 (2003)
- Reiser J, "Induction of B7-1 in podocytes is associated with nephrotic syndrome", J Clin Invest, 113, pp.1390~1397 (2004)
- Gandhi NA, "Commonality of the IL-4", IL-13 pathway in atopic diseases, 2017, pp.13, 425~437
- Corren J, "Role of interleukin-13 in asthma", Curr Allergy Asthma Rep, 13, pp.415~420 (2013)
- Bertelli R, "Regulatory T cells and minimal change nephropathy : in the midst of a complex network", Clin Exp Immunol, 183, pp.166~174 (2016)
- Shimada M, "Minimal change disease : a"two-hit"podocyte immune disorder", Pediatr Nephrol, 26, pp.645~649 (2011)
- Le Berre L, "Induction of T regulatory cells attenuates idiopathic nephrotic syndrome", J Am Soc Nephrol, 20, pp.57~67 (2009)
- Araya C, "T regulatory cell function in idiopathic minimal lesion nephrotic syndrome", Pediatr Nephrol, 24, pp.1691~1698 (2009)
- Tellier S, "Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome", Pediatr Nephrol, 28, pp.911~918 (2013)
- Iijima K, "Rituximab in steroid-sensitive nephrotic syndrome : lessons from clinical trials", Pediatr Nephrol, 33, pp.1449~1455 (2018)
- Iharada A, "Increased nitric oxide production by T-and B-cells in idiopathic nephrotic syndrome", Pediatr Nephrol, 24, pp.1033~1038 (2009)
- Elie V, "Physiopathology of idiopathic nephrotic syndrome : lessons from glucocorticoids and epigenetic perspectives", Pediatr Nephrol, 27, pp.1249~1256 (2012)
- Bakker WW, "Altered activity of plasma hemopexin in patients with minimal change disease in relapse", Pediatr Nephrol, 20, pp.1410~1415 (2005)
- Cheung PK, "Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin", Kidney Int, 57, pp.1512~1520 (2000)
- Lennon R, "Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes", J Am Soc Nephrol, 19, pp.2140~2149 (2008)
- Clement LC, "Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome", Nat Med, 17, pp.117~122 (2011)
- Clement LC, "Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome", Nat Med, 20, pp.37~46 (2014)
- Bertelli R, "Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease", Front Med, 5, pp.170~ (2018)
- Abbas AK, "T-cell stimulation : an abundance of B7s", Nat Med, 5, pp.1345~1346 (1999)
- Garin EH, "Urinary CD80 excretion increases in idiopathic minimal-change disease", J Am Soc Nephrol, 20, pp.260~266 (2009)
- Garin EH, "Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis", Kidney Int, 78, pp.296~302 (2010)
- Ling C, "Urinary CD80excretion is a predictor of good outcome in children with primary nephrotic syndrome", Pediatr Nephrol, 33, pp.1183~1187 (2018)
- Ishimoto T, "Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice", Nephrol Dial Transplantation, 28, pp.1439~1446 (2013)